Treatment of chronic hepatitis C in patients with kidney disease: contributions to the Clinical Practice Guideline of the Social Health Insurance of Peru (EsSalud)

Authors

  • Jose Armando Gonzales-Zamora Infectious Disease Division, Department of Medicine, Miller School of Medicine, University of Miami. Miami, Florida, Estados Unidos. 2 Peruvian American Medical Society (PAMS). Albuquerque, Nuevo México, Estados Unidos http://orcid.org/0000-0002-2768-9712
  • Linda Ponce-Rosas Peruvian American Medical Society (PAMS). Albuquerque, Nuevo México, Estados Unidos http://orcid.org/0000-0003-2951-9386
  • Jorge Alave-Rosas Peruvian American Medical Society (PAMS). Albuquerque, Nuevo México, Estados Unidos. Universidad Peruana Unión. Lima, Perú http://orcid.org/0000-0002-1178-2445

DOI:

https://doi.org/10.47892/rgp.2022.422.1360

Keywords:

Hepatitis C, tratamiento, enfermedad renal, Sofosbuvir.

Abstract

-

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Published

06/30/2022

How to Cite

1.
Gonzales-Zamora JA, Ponce-Rosas L, Alave-Rosas J. Treatment of chronic hepatitis C in patients with kidney disease: contributions to the Clinical Practice Guideline of the Social Health Insurance of Peru (EsSalud). Rev Gastroenterol Peru [nternet]. 2022 Jun. 30 [cited 2024 Nov. 23];42(2):141-2. vailable from: https://revistagastroperu.com/index.php/rgp/article/view/1360

Issue

Section

CARTAS AL EDITOR